U.S. label preparations
Medications beginning with T
17 results | Page 1 of 1
- Tarlatamab-dlle (Imdelltra)Reconstitution and dilution
- Tebentafusp-tebn (Kimmtrak)Dilution required
- Telisotuzumab vedotin-tllv (Emrelis)Reconstitution and dilution
- TenecteplaseAnticoagulation and hemostasisReconstitution only
- Teplizumab-mzwv (Tzield)Dilution required
- TerlipressinCardiovascular and vasoactiveReconstitution only
- Tislelizumab-jsgr (Tevimbra)Dilution required
- Tisotumab vedotin-tftv (Tivdak)Reconstitution and dilution
- Tividenofusp alfa-eknm (Avlayah)Reconstitution and dilution
- Tocilizumab-aazg (Tyenne)Dilution required
- Tocilizumab-anoh (Avtozma)Dilution required
- Tocilizumab-bavi (Tofidence)Dilution required
- Toripalimab-tpzi (Loqtorzi)Dilution required
- Trastuzumab-strf (Hercessi)Reconstitution and dilution
- Tremelimumab (Imjudo)Dilution required
- Treosulfan (Grafapex)Reconstitution only
- Trilaciclib (Cosela)Biologics and immunotherapyHistorical article / Reconstitution and dilution
Official label links, archived source snapshots, and reviewed local statements represent different levels of evidence work. Only statements with the required source mapping appear as reviewed local content.
See actual clinical evidence coverage